DRUG
Price
$42.24
Change
-$1.71 (-3.89%)
Updated
Sep 5 closing price
Capitalization
313.46M
OTLC
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
22.83M
79 days until earnings call
Interact to see
Advertisement

DRUG vs OTLC

Header iconDRUG vs OTLC Comparison
Open Charts DRUG vs OTLCBanner chart's image
Bright Minds Biosciences
Price$42.24
Change-$1.71 (-3.89%)
Volume$43.97K
Capitalization313.46M
Oncotelic Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$2.8K
Capitalization22.83M
DRUG vs OTLC Comparison Chart in %
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. OTLC commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a Hold and OTLC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (DRUG: $42.24 vs. OTLC: $0.05)
Brand notoriety: DRUG and OTLC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 82% vs. OTLC: 3%
Market capitalization -- DRUG: $313.46M vs. OTLC: $22.83M
DRUG [@Biotechnology] is valued at $313.46M. OTLC’s [@Biotechnology] market capitalization is $22.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileOTLC’s FA Score has 0 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • OTLC’s FA Score: 0 green, 5 red.
According to our system of comparison, OTLC is a better buy in the long-term than DRUG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 4 TA indicator(s) are bullish while OTLC’s TA Score has 6 bullish TA indicator(s).

  • DRUG’s TA Score: 4 bullish, 4 bearish.
  • OTLC’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, OTLC is a better buy in the short-term than DRUG.

Price Growth

DRUG (@Biotechnology) experienced а +8.63% price change this week, while OTLC (@Biotechnology) price change was -1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

OTLC is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRUG($313M) has a higher market cap than OTLC($22.8M). OTLC YTD gains are higher at: 50.000 vs. DRUG (17.268). OTLC has higher annual earnings (EBITDA): -3.36M vs. DRUG (-8.94M). DRUG has more cash in the bank: 51.4M vs. OTLC (88K). DRUG has less debt than OTLC: DRUG (141K) vs OTLC (13.5M). DRUG (0) and OTLC (0) have equivalent revenues.
DRUGOTLCDRUG / OTLC
Capitalization313M22.8M1,373%
EBITDA-8.94M-3.36M266%
Gain YTD17.26850.00035%
P/E RatioN/AN/A-
Revenue00-
Total Cash51.4M88K58,409%
Total Debt141K13.5M1%
FUNDAMENTALS RATINGS
OTLC: Fundamental Ratings
OTLC
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRUGOTLC
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBMLF0.710.02
+2.16%
Pacific Booker Minerals Inc.
CHGCY22.250.06
+0.27%
Chugai Pharmaceutical Co., Ltd.
NGKSY18.02N/A
N/A
NITERRA CO LTD.
TUFBY6.00N/A
N/A
Thai Union Group Public Company Limited
RSNUF0.03N/A
N/A
RENASCOR RES LTD.

DRUG and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRUG has been loosely correlated with WVE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if DRUG jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRUG
1D Price
Change %
DRUG100%
-3.89%
WVE - DRUG
44%
Loosely correlated
+1.34%
PHMMF - DRUG
44%
Loosely correlated
N/A
IVA - DRUG
43%
Loosely correlated
-0.54%
TVGN - DRUG
32%
Poorly correlated
-1.47%
ATYR - DRUG
31%
Poorly correlated
+2.56%
More

OTLC and

Correlation & Price change

A.I.dvisor tells us that OTLC and THAR have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and THAR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
+10.06%
THAR - OTLC
25%
Poorly correlated
-7.77%
DRUG - OTLC
20%
Poorly correlated
-3.89%
CANF - OTLC
20%
Poorly correlated
-0.05%
MMIRF - OTLC
15%
Poorly correlated
N/A
NDTP - OTLC
2%
Poorly correlated
N/A
More